Converting AI pilots into genuine P&L impact through execution, governance and accelerators
Over the past few years, organisations of every shape and size have poured money into AI, personalisation and smarter decisioning platforms.
We enable our clients to unlock research-driven insights in drug discovery and clinical development. bioXcelerate AI, our health data science sub-division, brings together a team of expert scientists who apply advanced statistics, machine learning and software engineering with academic depth and real-world focus.
